"Peptides promise results that leave people better than well, fitter than fit, yet despite getting glowing reviews on social media, most peptides have limited clinical evidence to support health benefits."
"In 2023 the Food and Drug Administration banned several peptides, including BPC-157, GHK-Cu, KPV and ipamorelin, from being produced in the U.S. by compounding pharmacies due to significant safety risks."
"Many peptides are imported from outside of the country, and many made here are marketed for research use only, as people seek them out on legally dubious gray markets."
Peptides are gaining popularity for their purported benefits in recovery, skin health, and muscle building, often promoted by influencers. Despite positive social media reviews, most peptides lack substantial clinical evidence for their effectiveness and safety. In 2023, the FDA banned several peptides due to significant safety risks, leading to their importation from gray markets. The demand for these substances continues, with discussions about potential legalization to improve access. Users are often drawn to the promises of enhanced health and fitness.
Read at www.scientificamerican.com
Unable to calculate read time
Collection
[
|
...
]